Singapore tries to give its flagging stock market a kickstart with a link to the NASDAQ, allowing firms to easily list in both places

SGX and Nasdaq will launch a dual-listing bridge later this year to let companies list in both the U.S. and Singapore, aiming to boost SGX liquidity and attract Southeast Asian issuers seeking U.S. capital while retaining regional visibility. The move targets larger issuers only (minimum market cap S$2 billion / ~$1.6 billion) and comes as SGX saw 2025 IPO proceeds rise to the highest level since 2019 and December turnover climb 29% year-on-year, but average daily turnover remains low at about $1.4 billion versus HKEX's $29 billion. Market participants say the bridge provides a streamlined pathway to U.S. depth and Asian growth, but caution it is not a 'silver bullet'—limited eligibility and the need for U.S. investors to trade during Singapore hours mean local liquidity constraints could persist.

Analysis

Market structure: The SGX–Nasdaq bridge concentrates upside into large-cap SE Asian and U.S. exchange incumbents. Winners: Nasdaq (NDAQ) via listing fees, trading-tech and extended-hours product demand; large-cap SE issuers (Grab, Sea) that meet the SGD2bn (~$1.6bn) threshold. Losers: mid/small-cap SGX names (market cap <SGD2bn) that remain illiquid and HKEX could lose some Southeast Asian cross-listing flow, though HK’s China pipeline cushions that loss.

Risk assessment: Tail risks include a regulatory spat (U.S.–China decoupling or SEC/SGX rule misalignment) that forces delistings, and operational frictions (clearing/settlement, time-zone liquidity mismatch) that keep Asian liquidity low. Immediate (days) — modest re-rating of exchange tech names; short-term (weeks–months) — first dual-list announcement catalysts; long-term (1–3 years) — potential modest SGX turnover lift if 3–5 issuers dual-list and Asian retail participates. Hidden dependency: USD liquidity and U.S. investor willingness to trade into Singapore hours.

Trade implications: Direct: establish a 1–2% long position in NDAQ ahead of launch later this year to capture incremental fee/market-data revenue and optionality, target 8–15% upside over 12 months. Tactical: buy 6–12 month call spreads on GRABW and SE (allocate 2–4% each) to capture re-rating from improved Asian liquidity while capping premium. Pair: long GRABW or SE vs short KWEB (China tech ETF) to express SE Asia outperformance vs China exposure.

Contrarian angles: Consensus overstates immediate SGX uplift — only handful of >SGD2bn firms qualify, so SGX structural liquidity likely improves incrementally, not revolutionarily. Underappreciated: Nasdaq may capture most economic value (extended-hours trading products, options volumes) while SGX gains brand cachet. Historical parallel: secondary-listing waves (HKEX 2014–19) started with a few large deals then required policy/tax incentives to scale—watch for SG policy moves. Unintended consequence: increased regulatory arbitrage and tax/custody shifts that can raise compliance costs for issuers and deter midcaps.

Key Decisions for Investors

• Establish a 1–2% long position in NDAQ (Nasdaq) ahead of the bridge rollout later this year; set a 12-month target of +8–15% and a stop-loss at -8% to capture listing-fee and extended-hours product upside.
• Allocate 2–4% positions to 6–12 month bull-call spreads on GRABW and SE (size each to cost no more than 1% of portfolio) to play potential Asian liquidity re-rating while limiting premium risk.
• Enter a pair trade: long GRABW (or SE) equal-weight vs short KWEB (China tech ETF) 1:1 to express Southeast Asia listing arbitrage and de-emphasize China-specific regulatory risk; trim if KWEB outperforms by >10% in 3 months.
• Do not increase exposure to small/mid-cap SGX-only stocks until at least 3 dual-listings execute; monitor first dual-list within 90 days of launch and require >$250m average daily SGD turnover post-listing before adding SGX small-cap exposure.